An international working group advising on therapies for juvenile MG recommended starting cholinesterase inhibitors at 0.5 to 1 mg/kg every 4 to 6 h and increasing the dose to 7 mg/kg/day in divided doses for symptom control (3). The gene discussed is BCHE; the disease is myasthenia gravis.